New consensus on assessing carcinogenic risks of gene therapies

A new article in the peer-reviewed journal Human Gene Therapy describes the consensus reached by invited experts who participated in a meeting to evaluate the potential carcinogenicity of gene therapies.

Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle

Regeneron on Monday successfully flipped a lower court’s decision in a hotly-contested case against Novartis regarding the companies’ competing eye injections. The US Court of

March 19, 2024

New computational pipeline revolutionizes personalized cancer vaccine design

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets

October 12, 2024

Study: People with a sweet tooth at higher risk of developing depression, diabetes, and stroke

People with a preference for sweets are at a higher risk of developing depression, diabetes, and suffering a stroke, according to new research from the

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.